Uptake of Isoniazid Preventive Therapy and Its Associated Factors among People Living with HIV Attending Jinja Regional Referral Hospital, Uganda

Bataringaya Bathsheba

Faculty of Clinical Medicine and Dentistry, Kampala International University, Uganda

ABSTRACT

This study investigates the factors influencing the uptake of isoniazid preventive therapy among HIV patients at Jinja Regional Referral Hospital in Uganda. The research design is a cross-sectional descriptive design, with a simple random sampling procedure. The study area is the OPD clinic of Jinja Regional Referral Hospital, one of the thirteen Regional Referral Hospitals in Uganda. Information was collected from the target population is all HIV positive patients using a questionnaire. This study focused on content validity, reliability, and data collection procedures. The study also analyzed the relationship between socio-demographic factors, healthcare system-related factors, patient-related factors, and uptake of Isoniazid among people living with HIV. The findings showed that the majority of participants on HIV/AIDS treatment and taking isoniazid regularly were between 41-60 years old, with young patients not liking taking isoniazid. The study also found that females were more likely to be adherent to treatment than males, while Christians and employed people were more likely to take isoniazids. Family support is also crucial for adherence to isoniazid treatment. Health-related factors affecting regular uptake include distance from health facilities, poor patient-physician relations, and lack of availability of service providers. Patient-related factors also affect the regular uptake of isoniazid. The study concludes that youth participants aged 20-40 years dislike taking isoniazid, while middle-aged and older patients aged 41-60 years do. The government should increase IPT services to different health facilities and provide free services, including the provision of isoniazid treatments, to help these patients.

Keywords: Tuberculosis, Mycobacterium tuberculosis, HIV, Isoniazid

CITE AS: Bataringaya Bathsheba (2024). Uptake of Isoniazid Preventive Therapy and Its Associated Factors among People Living with HIV Attending Jinja Regional Referral Hospital, Uganda. RESEARCH INVENTION JOURNAL OF RESEARCH IN MEDICAL SCIENCES 3(1):58-65.